STRS Ohio’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.03M | Buy |
38,166
+9,384
| +33% | +$706K | 0.01% | 510 |
|
|
2026
Q1 | $2.16M | Buy |
28,782
+24,994
| +660% | +$1.97M | 0.01% | 569 |
|
|
2025
Q4 | $300K | Buy |
3,788
+72
| +2% | +$5.42K | ﹤0.01% | 1326 |
|
|
2025
Q3 | $243K | Buy |
3,716
+2
| +0.1% | +$98 | ﹤0.01% | 1447 |
|
|
2025
Q2 | $147K | Buy |
+3,714
| New | +$122K | ﹤0.01% | 1759 |
|
|
2024
Q2 | – | Sell |
-29,965
| Closed | -$1.3M | – | 2020 |
|
|
2024
Q1 | $1.3M | Buy |
29,965
+5,186
| +21% | +$247K | 0.01% | 828 |
|
|
2023
Q4 | $1.25M | Buy |
+24,779
| New | +$1.19M | 0.01% | 810 |
|
|
2023
Q1 | – | Sell |
-25,791
| Closed | -$974K | – | 1998 |
|
|
2022
Q4 | $974K | Buy |
25,791
+8,483
| +49% | +$357K | ﹤0.01% | 942 |
|
|
2022
Q3 | $765K | Buy |
+17,308
| New | +$729K | ﹤0.01% | 1066 |
|
|
2021
Q2 | – | Sell |
-1,454
| Closed | -$65K | – | 2325 |
|
|
2021
Q1 | $65K | Hold |
1,454
| – | – | ﹤0.01% | 2005 |
|
|
2020
Q4 | $82K | Buy |
+1,454
| New | +$72.5K | ﹤0.01% | 1929 |
|
|
2019
Q3 | – | Sell |
-3,068
| Closed | -$197K | – | 2107 |
|
|
2019
Q2 | $197K | Buy |
3,068
+566
| +23% | +$40K | ﹤0.01% | 1703 |
|
|
2019
Q1 | $203K | Buy |
+2,502
| New | +$161K | ﹤0.01% | 1669 |
|
|
2016
Q2 | – | Sell |
-2,602
| Closed | -$105K | – | 1959 |
|
|
2016
Q1 | $105K | Buy |
2,602
+161
| +7% | +$6.54K | ﹤0.01% | 1653 |
|
|
2015
Q4 | $151K | Buy |
2,441
+330
| +16% | +$17.8K | ﹤0.01% | 1576 |
|
|
2015
Q3 | $85K | Sell |
2,111
-342
| -14% | -$17.7K | ﹤0.01% | 1689 |
|
|
2015
Q2 | $141K | Sell |
2,453
-30,300
| -93% | -$1.93M | ﹤0.01% | 1623 |
|
|
2015
Q1 | $2.08M | Buy |
32,753
+2,553
| +8% | +$173K | 0.01% | 610 |
|
|
2014
Q4 | $1.86M | Buy |
30,200
+4,000
| +15% | +$197K | 0.01% | 624 |
|
|
2014
Q3 | $1.02M | Buy |
26,200
+2,500
| +11% | +$88.6K | ﹤0.01% | 750 |
|
|
2014
Q2 | $816K | Sell |
23,700
-2,300
| -9% | -$72.4K | ﹤0.01% | 910 |
|
|
2014
Q1 | $1.12M | Sell |
26,000
-700
| -3% | -$33.9K | 0.01% | 684 |
|
|
2013
Q4 | $1.06M | Sell |
26,700
-5,500
| -17% | -$196K | ﹤0.01% | 715 |
|
|
2013
Q3 | $1.21M | Buy |
32,200
+9,400
| +41% | +$281K | 0.01% | 720 |
|
|
2013
Q2 | $613K | Buy |
+22,800
| New | +$485K | ﹤0.01% | 1201 |
|
Other funds holding IONS
STRS Ohio's IONS Position: Q2 2026 in Review
STRS Ohio increased its Ionis Pharmaceuticals (IONS) stake by 33% in Q2 2026, buying an estimated $706K and bringing the position to 38,166 shares worth $3.03M. The position accounts for 0.01% of the portfolio, ranked #510.
STRS Ohio first reported a position in IONS in Q2 2013 and has held it in 25 quarters since. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.
- STRS Ohio held 38,166 shares of Ionis Pharmaceuticals worth $3.03M as of Q2 2026.
- STRS Ohio bought 9,384 Ionis Pharmaceuticals shares in Q2 2026, an estimated $706K.
- Ionis Pharmaceuticals made up 0.01% of STRS Ohio's portfolio in Q2 2026, its #510 holding.
- STRS Ohio first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 25 quarters since.
- 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.
Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.